Please login to the form below

tissue engineering

This page shows the latest tissue engineering news and features for those working in and with pharma, biotech and healthcare.

Regenerative medicine aims to repair injuries or diseased organs using biomaterials, gene therapy, cell therapy and tissue engineering.

Organs on demand: the future of transplants

Ridley Scott's 1982 dystopian thriller describes a world in which bioengineered human beings or 'replicants' can be made using genetic engineering and tissue culture techniques. ... Widely regarded as a science fiction classic, Blade Runner arguably
UK regenerative medicine projects get £8.5m boost

The TSB will provide £5.9m of the funding while the Medical Research Council (MRC), the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council will ... Regenerative medicine is an
Growing together

At the end of 2008, to serve the need for getting advanced therapies to patients across Europe, the first EU legislation on gene therapy, somatic cell therapy and tissue engineering products ... and tissue engineering products.
EMA grants CVD therapy ATMP certificate

ATMPs are advanced biotechnology products based on cell therapy, gene therapy, or tissue engineering and t2c001 is a somatic cell therapy product derived from autologous bone marrow.
Switched on

Stem cell research may also result in tissue engineered products with therapeutic application in heart disease and skin and cartilage replacement. ... For some, the ultimate goal is to use tissue engineering to replace failing organs.

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

The cell therapy, gene therapy and tissue engineering sector raised $2.9bn in venture capital in 2018 – twice the 2017 amount.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Histogenics names former MedImmune president as CEO

In his new role, he will lead a company that specialises in combining cell therapy and tissue engineering technologies to develop products primarily for orthopaedic tissue repair. ... This includes lead candidate NeoCart – a cartilage tissue implant in

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Revolutionizing 3D Bioprinting & Disrupting the Drug Development Industry

Christine Whiteside, COO of VoxCell BioInnovation, discusses 3D bioprinting, including current and future applications and key barriers to realizing its full potential. She also shares her tips for getting new healthcare and biotech startups off the

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

No results were found

Add my company

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Whitepaper: Closing the gap with compelling healthcare communications: Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers: Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs: It’s not a question of ‘if,’ it’s a question of ‘when.’...

Email:
Password: